BHVN

Biohaven is a drug development company working on treatments for diseases affecting the immune system, brain, and cancer. The company has multiple experimental drugs in various stages of testing, including candidates for Parkinson's disease, epilepsy, obesity, rheumatoid arthritis, and several types of cancer. Most of these drugs are still in early-stage human trials and have not yet been approved by regulators. The company was incorporated in 2022 and is based in New Haven, Connecticut.